Loading clinical trials...
Loading clinical trials...
A Phase 1, Open-label, Randomized, 3-period Crossover Taste Assessment Study to Characterize the Palatability of SHP429 When the Contents Are Sprinkled Onto Soft Foods or Emptied Into a Cup and Administered With Water in Healthy Adult Subjects
Conditions
Interventions
Mesalamine
Locations
1
United States
Clinical Pharmacology of Miami, Inc.
Miami, Florida, United States
Start Date
June 2, 2014
Primary Completion Date
June 19, 2014
Completion Date
June 19, 2014
Last Updated
June 3, 2021
NCT07310264
NCT06716502
NCT06290258
NCT00090662
NCT07483606
NCT07310901
Lead Sponsor
Shire
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions